Levofloxacin 1a Pharma (Levofloxacin Hemihydrate)

Levofloxacin blocks two key bacterial enzymes—DNA gyrase (topoisomerase II) and topoisomerase IV—by binding to the enzyme‑DNA complex. This inhibition prevents DNA supercoiling and separation, halting replication and transcription, which ultimately leads to bacterial cell death. The dual‑target action gives it activity against a broad range of Gram‑negative and Gram‑positive bacteria.

The exact dose of Levofloxacin 1a Pharma is set by the prescribing healthcare professional based on the specific infection, its severity, the patient’s renal function, age, and any other relevant clinical factors. No universal dosing regimen is provided here; the prescriber will tailor the regimen to each individual case.

Levofloxacin is classified as a pregnancy‑category drug with limited safety data, and it is generally avoided unless the potential benefit outweighs the risk to the fetus. It is also excreted in breast milk, so breastfeeding mothers should discuss alternatives with their clinician. The decision rests on a careful risk‑benefit assessment by the prescriber.

To request Levofloxacin 1a Pharma, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will ask for trade or institutional credentials. The sales team then replies with pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import documentation.

Levofloxacin offers once‑daily dosing and a broad spectrum that covers many Gram‑negative and Gram‑positive organisms, similar to other fluoroquinolones such as ciprofloxacin. Compared with beta‑lactam antibiotics, it may be chosen for patients with penicillin allergy or when resistance to beta‑lactams is suspected. However, safety considerations like tendon risk and QT prolongation are shared across the class.

Levofloxacin 1a Pharma should be stored at temperatures below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability throughout its shelf life.

Levofloxacin 1a Pharma is administered orally, typically as a tablet or capsule taken with a full glass of water. It may be taken with or without food, but patients should avoid concurrent intake of antacids or mineral supplements that could interfere with absorption. The exact regimen is determined by the prescribing clinician.

Serious risks include tendon rupture or inflammation, especially in older adults or those on corticosteroids; QT interval prolongation that can lead to cardiac arrhythmias; severe hypersensitivity reactions such as Stevens‑Johnson syndrome; and Clostridioides difficile‑associated colitis. Patients should be instructed to seek immediate medical attention if they experience sudden tendon pain, palpitations, or severe skin reactions.

Levofloxacin should be avoided in patients with a known hypersensitivity to levofloxacin or other fluoroquinolones, those with a history of tendon disorders related to fluoroquinolone use, and individuals taking medications that significantly prolong the QT interval without appropriate monitoring. Caution is also advised for patients with severe renal impairment, uncontrolled epilepsy, or pregnant women unless the benefit clearly outweighs the risk.